PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 78 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $331,873 | +7957.1% | 22,638 | +0.0% | 0.00% | – |
Q4 2023 | $4,119 | -38.9% | 22,633 | +0.1% | 0.00% | – |
Q3 2023 | $6,737 | +63.8% | 22,606 | -9.0% | 0.00% | – |
Q2 2023 | $4,112 | -91.4% | 24,847 | -49.4% | 0.00% | – |
Q1 2023 | $47,906 | -7.4% | 49,084 | -1.3% | 0.00% | – |
Q4 2022 | $51,743 | +69823.0% | 49,753 | -23.1% | 0.00% | – |
Q3 2022 | $74 | -50.3% | 64,683 | -18.7% | 0.00% | – |
Q2 2022 | $149 | -100.0% | 79,532 | -59.2% | 0.00% | – |
Q1 2022 | $591,000 | -67.6% | 195,010 | -59.6% | 0.00% | – |
Q4 2021 | $1,824,000 | -29.2% | 482,655 | -3.2% | 0.00% | -100.0% |
Q3 2021 | $2,578,000 | +3043.9% | 498,581 | +2240.3% | 0.00% | – |
Q2 2021 | $82,000 | -86.5% | 21,304 | -91.0% | 0.00% | – |
Q1 2021 | $609,000 | -21.7% | 237,187 | -23.8% | 0.00% | – |
Q4 2020 | $778,000 | +11.6% | 311,224 | -7.7% | 0.00% | – |
Q3 2020 | $697,000 | -36.8% | 337,112 | -5.2% | 0.00% | – |
Q2 2020 | $1,103,000 | +45.3% | 355,706 | +6.8% | 0.00% | – |
Q1 2020 | $759,000 | -30.6% | 333,181 | +10.2% | 0.00% | – |
Q4 2019 | $1,094,000 | -4.5% | 302,355 | -10.0% | 0.00% | – |
Q3 2019 | $1,146,000 | -48.6% | 336,121 | -29.1% | 0.00% | -100.0% |
Q2 2019 | $2,228,000 | +22.6% | 474,035 | -12.6% | 0.00% | 0.0% |
Q1 2019 | $1,817,000 | +9.3% | 542,397 | -13.2% | 0.00% | 0.0% |
Q4 2018 | $1,662,000 | -53.7% | 624,869 | -2.5% | 0.00% | 0.0% |
Q3 2018 | $3,590,000 | +1.3% | 641,094 | -8.3% | 0.00% | 0.0% |
Q2 2018 | $3,544,000 | -22.1% | 699,041 | +4.8% | 0.00% | 0.0% |
Q1 2018 | $4,550,000 | +129.9% | 667,065 | +154.4% | 0.00% | – |
Q4 2017 | $1,979,000 | +244.2% | 262,220 | +162.6% | 0.00% | – |
Q3 2017 | $575,000 | +858.3% | 99,844 | +735.4% | 0.00% | – |
Q2 2017 | $60,000 | – | 11,952 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,360,000 | $6,895,000 | 5.06% |
Omega Fund Management, LLC | 778,230 | $3,946,000 | 2.91% |
BVF INC/IL | 5,346,838 | $27,108,000 | 2.65% |
Virtus ETF Advisers LLC | 152,550 | $773,000 | 0.68% |
SPHERA FUNDS MANAGEMENT LTD. | 842,632 | $4,272,000 | 0.59% |
Tekla Capital Management LLC | 2,087,380 | $10,583,000 | 0.40% |
Schonfeld Strategic Advisors LLC | 828,600 | $4,201,000 | 0.23% |
Orbimed Advisors | 3,140,000 | $15,920,000 | 0.19% |
Lombard Odier Asset Management (USA) Corp | 563,878 | $2,859,000 | 0.19% |
Rhenman & Partners Asset Management AB | 300,000 | $1,521,000 | 0.16% |